QTREX Quantum Ltd Dossier
|
SectorInformation Technology IndustryTechnology Hardware, Storage & Peripherals Beta (adjusted)3.17 Intrinsic Value Insufficient data for a value estimateNot enough reliable inputs to publish a fair value for this company yet. Market Price $0.78Price as of 1 Oct 2026 Data confidenceNot applicable Market Cap $52.6M Shares Outstanding 67.1M diluted All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary QTREX Quantum Ltd (formerly Inspira Technologies Oxy B.H.N. Ltd) has successfully pivoted from a clinical-stage medical device developer to a high-potential quantum computing infrastructure play. By acquiring Nano Dimension's Additively Manufactured Electronics (AME) platform, QTREX is uniquely positioned to solve quantum computing's primary physical bottleneck: cryogenic interconnect scaling inside dilution cryostats. While the company remains pre-profit and carries substantial going-concern risks, its proprietary 3D-printed monolithic interconnect structures offer a massive structural upgrade over bulky, hand-assembled coaxial wiring. Early commercial traction, including a 97% yield validation and orders from government-owned entities, validates the technology's viability. This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Street view · analyst 12-month targets Low · most bearish analyst$5.00 Mean target$5.00 High · most bullish analyst$5.00 Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario $5.0020% The specialized polymer resins crack or fail under long-term cryogenic stress testing, leading to system-wide failures in deployed interconnects. Commercial adoption stalls as major quantum hardware developers opt to keep interconnect manufacturing in-house or utilize alternative technologies. Cash reserves are depleted faster than expected, forcing highly dilutive equity raises or triggering going-concern insolvency. Base CaseCentral scenario $5.0050% Matches the consensus meanQTREX continues to execute on its current pipeline, delivering on its initial commercial orders for government-owned entities and defense contractors. The newly established U.S. subsidiary successfully secures federal research and development contracts. The company maintains its 97% AME system yield validation rate and gradually monetizes its legacy medical assets to offset its cash burn, keeping the business funded through 2027. Bull CaseUpside scenario $5.0030% The company's proprietary polymer resins and nano inks successfully pass long-term stress tests at extreme cryogenic temperatures (15-20 millikelvin). QTREX secures a multi-million dollar strategic supply agreement with a top-five global quantum computing company, driving rapid commercial scaling. Warrants are fully exercised for cash, providing $4.75 million in non-dilutive working capital, while the legacy medical portfolio is successfully sold or spun off. Scenarios are anchored to street consensus at the research date, with our probabilities and rationale. Key Investment Merits
Key Investment Risks
Thesis Invalidation Triggers
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |